摘要
目的:分析中医治未病理论在慢性乙型病毒性肝炎(简称乙肝)治疗中的应用价值。方法:以2017年11月-2019年11月作为本次研究时间,把我院肝病内科接收的慢性乙型肝炎患者58例作为研究对象,对照组给予常规西医治疗,研究组则结合中医治未病理论进行治疗,观察其临床疗效以及肝功能指标改善情况。结果:同对照组相比,研究组患者天门冬氨酸氨基转移酶(Aspartate Aminotransferase,AST)、丙氨酸氨基转移酶(Alanine Aminotransferase,ALT)、总胆红素(Total Bilirubin,TBIL)的肝功能指标水平均更低,差异有统计学意义(P<0.05);研究组患者的治疗有效率明显要高于对照组,差异有统计学意义(P<0.05);研究组患者治疗后乙肝病毒的脱氧核糖核酸(Hepatitis Bvirus Virus DNA,HBV-DNA)血清阴转率明显要高于对照组,差异有统计学意义(P<0.05);研究组患者治疗后血清乙型肝炎E抗原(Hepatitis Be Antigen,HBeAg)阴转率明显要低于对照组,差异统计学意义(P<0.05)。结论:临床上在治疗慢性乙型肝炎疾病时将中医治未病理论运用其中,可使患者的临床症状和肝功能水平得到明显改善,利于总体治疗效果的提高,值得推广。
Objective:To analyze the application value of TCM theory of prevention of disease on chronic hepatitis B.Methods:58 patients were divided into two groups.The control group was given conventional Western medicine,and the study group was treated by TCM theory of prevention of disease.Results:Compared with the control group,the AST,ALT,TBIL of liver in the study group were lower,with statistically significant differences(P<0.05).The effective rate in the study group was significantly higher than the control group,and the difference was statistically significant(P<0.05).The HBV-DNA in the study group was significantly higher,and the HBeAg negative conversion rate was significantly lower than the control group,with statistically significant differences(P<0.05).Conclusion:TCM theory of prevention of disease on chronic hepatitis B can significantly improve the clinical symptoms and liver function,improve the overall effect,and is worthy of promotion.
出处
《中医临床研究》
2020年第29期70-73,共4页
Clinical Journal Of Chinese Medicine
关键词
慢性乙型肝炎
中医治未病
应用价值
Chronic hepatitis B
TCM theory of prevention of disease
Application value
